{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T18:17:21Z","timestamp":1743013041604},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T00:00:00Z","timestamp":1664323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T00:00:00Z","timestamp":1664323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Institutes of Health, Intramural Research Program"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Desmoid-type fibromatosis (DTF) is a rare benign lesion that usually arises from the abdominal wall or extremities and rarely from the mesentery or intrabdominal organs. Malignant peritoneal mesothelioma is also a rare, yet aggressive disease. To our knowledge, this is the first case report of desmoid-type fibromatosis in the setting of malignant peritoneal mesothelioma.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>An early 30-year-old female was referred to our center for large intra-abdominal mass concerning for recurrent malignant peritoneal mesothelioma after previous cytoreductive surgery with hyperthermic intraperitoneal chemotherapy and adjuvant chemotherapy. Further investigation revealed a large mesenteric mass, which was resected en bloc with the cecum and terminal ileum. Pathologic findings confirmed a surprising diagnosis of desmoid-type fibromatosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>No adjuvant therapy was offered to this patient due to negative tumor margins; however, close follow-up will be provided for recurrence of both malignant peritoneal mesothelioma and desmoid-type fibromatosis, which can be differentiated in the future via biopsy in this patient.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12957-022-02784-y","type":"journal-article","created":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T12:03:14Z","timestamp":1664366594000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Desmoid-type fibromatosis in the setting of malignant peritoneal mesothelioma: a case report of two rare diseases"],"prefix":"10.1186","volume":"20","author":[{"given":"Stephanie N.","family":"Gregory","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audra A.","family":"Satterwhite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. Richard","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew M.","family":"Blakely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,28]]},"reference":[{"issue":"Suppl 1","key":"2784_CR1","doi-asserted-by":"publisher","first-page":"S120","DOI":"10.21037\/tlcr.2019.12.15","volume":"9","author":"A Greenbaum","year":"2020","unstructured":"Greenbaum A, Alexander HR. Peritoneal mesothelioma. Transl Lung Cancer Res. 2020;9(Suppl 1):S120\u201332.","journal-title":"Transl Lung Cancer Res"},{"issue":"3","key":"2784_CR2","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.soc.2018.02.010","volume":"27","author":"CY Li","year":"2018","unstructured":"Li CY, Alexander HR Jr. Peritoneal metastases from malignant mesothelioma. Surg Oncol Clin N Am. 2018;27(3):539\u201349.","journal-title":"Surg Oncol Clin N Am"},{"issue":"4","key":"2784_CR3","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1097\/PAP.0000000000000077","volume":"22","author":"JA Goldstein","year":"2015","unstructured":"Goldstein JA, Cates JM. Differential diagnostic considerations of desmoid-type fibromatosis. Adv Anat Pathol. 2015;22(4):260\u20136.","journal-title":"Adv Anat Pathol"},{"issue":"10","key":"2784_CR4","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1093\/annonc\/mdx323","volume":"28","author":"B Kasper","year":"2017","unstructured":"Kasper B, Baumgarten C, Garcia J, Bonvalot S, Haas R, Haller F, et al. An update on the management of sporadic desmoid-type fibromatosis: a European Consensus initiative between sarcoma patients EuroNet (SPAEN) and European organization for research and treatment of cancer (EORTC)\/soft tissue and bone sarcoma group (STBSG). Ann Oncol. 2017;28(10):2399\u2013408.","journal-title":"Ann Oncol"},{"issue":"1","key":"2784_CR5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s40487-016-0017-z","volume":"4","author":"JH Howard","year":"2016","unstructured":"Howard JH, Pollock RE. Intra-abdominal and abdominal wall desmoid fibromatosis. Oncol Ther. 2016;4(1):57\u201372.","journal-title":"Oncol Ther"},{"key":"2784_CR6","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ijscr.2017.02.050","volume":"33","author":"SD Couto Netto","year":"2017","unstructured":"Couto Netto SD, Teixeira F Jr, Menegozzo CAM, Albertini A, Akaishi EH, Utiyama EM. Abdominal wall reconstruction after desmoid type fibromatosis radical resection: case series from a single institution and review of the literature. Int J Surg Case Rep. 2017;33:167\u201372.","journal-title":"Int J Surg Case Rep"},{"issue":"2","key":"2784_CR7","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/jso.24117","volume":"113","author":"L Koskenvuo","year":"2016","unstructured":"Koskenvuo L, Peltomaki P, Renkonen-Sinisalo L, Gylling A, Nieminen TT, Ristimaki A, et al. Desmoid tumor patients carry an elevated risk of familial adenomatous polyposis. J Surg Oncol. 2016;113(2):209\u201312.","journal-title":"J Surg Oncol"},{"key":"2784_CR8","first-page":"2312617","volume":"2017","author":"C Hapgood","year":"2017","unstructured":"Hapgood C, DeLong A. Recurrent enlarging mesenteric desmoid tumor following remote surgical resection. Case Rep Radiol. 2017;2017:2312617.","journal-title":"Case Rep Radiol"},{"issue":"6","key":"2784_CR9","volume":"11","author":"PA Ebeling","year":"2019","unstructured":"Ebeling PA, Fun T, Beale K, Cromer R, Kempenich JW. Primary desmoid tumor of the small bowel: a case report and literature review. Cureus. 2019;11(6): e4915.","journal-title":"Cureus"},{"issue":"2","key":"2784_CR10","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.21873\/invivo.12362","volume":"35","author":"S Omori","year":"2021","unstructured":"Omori S, Ito S, Kimura K, Higashi T, Ohgaki K, Maehara S, et al. Intra-abdominal desmoid-type fibromatosis mimicking diverticulitis with abscess: a case report. In Vivo. 2021;35(2):1151\u20135.","journal-title":"In Vivo"},{"issue":"9","key":"2784_CR11","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1097\/PAS.0b013e3182556def","volume":"36","author":"S Barak","year":"2012","unstructured":"Barak S, Wang Z, Miettinen M. Immunoreactivity for calretinin and keratins in desmoid fibromatosis and other myofibroblastic tumors: a diagnostic pitfall. Am J Surg Pathol. 2012;36(9):1404\u20139.","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"2784_CR12","first-page":"79","volume":"7","author":"HR Alexander Jr","year":"2016","unstructured":"Alexander HR Jr, Burke AP. Diagnosis and management of patients with malignant peritoneal mesothelioma. J Gastrointest Oncol. 2016;7(1):79\u201386.","journal-title":"J Gastrointest Oncol"},{"issue":"11","key":"2784_CR13","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.5858\/2005-129-1407-IDOEMA","volume":"129","author":"NG Ordonez","year":"2005","unstructured":"Ordonez NG. Immunohistochemical diagnosis of epithelioid mesothelioma: an update. Arch Pathol Lab Med. 2005;129(11):1407\u201314.","journal-title":"Arch Pathol Lab Med"},{"issue":"5","key":"2784_CR14","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/S0002-9610(05)81243-7","volume":"159","author":"R Lopez","year":"1990","unstructured":"Lopez R, Kemalyan N, Moseley HS, Dennis D, Vetto RM. Problems in diagnosis and management of desmoid tumors. Am J Surg. 1990;159(5):450\u20133.","journal-title":"Am J Surg"},{"key":"2784_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.622626","volume":"11","author":"AC Braun","year":"2021","unstructured":"Braun AC, Campos FAB, Abdallah EA, Ruano APC, Medina TDS, Tariki MS, et al. Circulating tumor cells in desmoid tumors: new perspectives. Front Oncol. 2021;11: 622626.","journal-title":"Front Oncol"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-022-02784-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-022-02784-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-022-02784-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T12:06:06Z","timestamp":1664366766000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-022-02784-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,28]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2784"],"URL":"https:\/\/doi.org\/10.1186\/s12957-022-02784-y","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,28]]},"assertion":[{"value":"12 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was obtained by the National Institutes of Health Intramural Institutional Review Board at the institute: National Institutes of Health in Bethesda, Maryland. NIH Federal wide Assurance: FWA no. 0005897. Parent institution\/organization: IORG no. 00010. Committee Reference Number: IRB00011862 (National Institutes of Health IRB #10). IRB type: OHRP\/FDA. Patient signed the consent to participate in a clinical research study through the National Cancer Institute at the NIH Clinical Center.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent is obtained from the patient for publication of this case report and the accompanying images.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"317"}}